A South Carolina man and woman have filed a power morcellator lawsuit against Johnson & Johnson’s Ethicon unit. The couple claims that Johnson & Johnson’s device caused the woman to develop uterine fibroid cancer when it spread unsuspected cancerous tissue throughout her abdomen during a myomectomy procedure.
Power morcellators are a type of medical instrument used in minimally invasive, or laparoscopic, surgery to cut up large masses of tissue into ...
continue reading...
When a medical device is thought to have contributed to the death or serious injury of a patient, the manufacturer of that device is required by federal law to report that event to government regulators. Now, there is strong evidence to suggest that the FBI is investigating the possibility of criminal wrongdoing by Johnson & Johnson, as well as other manufacturers of power morcellators, for their failure to ...
The FDA released a statement discouraging the use of power morcellators in gynecological procedures because of significant cancer risks. A story by CBS Pittsburgh reports of a new study by Columbia University that further confirmed that power morcellators can spread undiagnosed stage 1 cancer.
The Columbia University study concluded that an estimated 1 in 368 women have uterine cancer at the time they undergo a gynecologic procedure. As a result, doctors may be ...
continue reading...A panel of Food and Drug Administration experts says that it is unlikely that power morcellation can be used to remove fibroids from women without the risk of spreading undetected cancers to other parts of the body. The FDA takes into consideration the opinions of its health advisors on these panels when making regulatory decisions about medical devices.
Power morcellators are used in the removal of fibroids and in some hysterectomies. Fibroids can cause ...
continue reading...After much speculation about the risk of spreading cancer with power morcellators, a study published in the Journal of the American Medical Association has assembled information on this risk. The risk was quantified from a review of data from over 200,000 patients.
The medical records review showed that 36,470 women had procedures where the uterus was fragmented using morcellation. Of those, one in every 368 women had an undiagnosed uterine cancer, resulting in 99 patients, or about ...
continue reading...Power morcellation was, until recently, considered a reasonable option for women seeking treatment for uterine fibroids. Amidst FDA warnings and various recalls, this option has been largely advised against. An article in the Wall Street Journal discusses the alternatives to power morcellation that are available to women that want to avoid this risky procedure.
Laparoscopic power morcellators are currently being investigated regarding their potential risk in spreading cancerous tumors in women. ...
continue reading...
